从同一健康视角看产ESBL和质粒头孢菌素酶大肠埃希菌的循环:一篇叙述性综述
该叙述性综述检索2010至2024年PubMed、Scopus和Google Scholar文献,分析产ESBL/质粒头孢菌素酶大肠埃希菌在人、动物和环境间的跨部门循环。全基因组测序等高分辨方法显示高收入国家以部门内循环为主,而中低收入国家存在频繁跨部门传播,提示需区域特异性防控策略。
要点
- 高收入国家产ESBL/pAmpC大肠埃希菌以部门内循环为主,人际传播是防控重点。
- 中低收入国家人、动物和环境间存在频繁跨部门传播,需加强卫生与生物安全。
- 质粒在ESBL/pAmpC基因循环中的作用可能被低估。
核心结论
- 产ESBL/pAmpC大肠埃希菌的循环呈现区域异质性:高收入国家以部门内循环为主,中低收入国家存在显著跨部门循环。
研究设计与样本
- 叙述性综述检索2010至2024年PubMed、Scopus和Google Scholar文献,纳入涉及人、动物和环境部门的ESBL/pAmpC大肠埃希菌循环研究。
主要发现
- 早期基于序列型、耐药基因和质粒复制子比较的研究提示人-动物传播,但全基因组测序揭示高收入国家循环 largely compartmentalized。
- 中低收入国家的类似研究显示人、动物和环境间频繁跨部门传播。
- 许多作者强调质粒在ESBL/pAmpC基因循环中的作用可能被低估。
临床怎么用
- 高收入国家防控应侧重限制人际传播,中低收入国家应加强卫生和生物安全措施。
- 采用全基因组测序等高分辨方法可更准确评估跨部门传播。
局限性
- 纳入研究在采样策略、地理背景和分离株比较方法上异质性大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The global rise of extended-spectrum β-lactamase (ESBL) and plasmid-borne cephalosporinase (pAmpC) producing Enterobacterales is a major health concern. Their increasing prevalence in both humans and animals underscores the need for One Health surveillance, for which Escherichia coli has been recognized as a key indicator. While many studies have investigated the circulation of ESBL/pAmpC-producing E. coli (ESBL/pAmpC-Ec) across human, animal, and environmental sectors, the extent to which animals contribute to human acquisition remains unclear. OBJECTIVES: This review provides an overview of the intersectoral circulation of ESBL/pAmpC-Ec and evaluates the potential role of animals as a reservoir for human colonization. SOURCES: Publications (2010-2024) identified through PubMed, Scopus, and Google Scholar, on ESBL/pAmpC-Ec circulation across human, animal, and environmental sectors (excluding studies on human-environment, animal-environment, and human-food only) were reviewed considering the included sectors, comparison methods, and geographical context. CONTENT: Surveillance approaches varied widely between studies, shaped by sampling strategies, geographical context, and isolated comparison methods. Advances in genomic methods have refined our understanding of ESBL/pAmpC-Ec circulation between sectors. Early studies, mostly conducted in high-income countries (HICs), suggested human-animal transmission based on comparisons of ESBL/pAmpC-Ec sequence types, resistance genes, and plasmid replicons. However, these findings were challenged by the introduction of more discriminating comparison methods such as whole-genome sequencing, which revealed a largely compartmentalized circulation of ESBL/pAmpC-Ec in HICs. Similar studies in low- and middle-income countries (LMICs) shifted this paradigm, demonstrating frequent cross-sectoral transmission across humans, animals, and the environment. Many authors also highlighted the likely underestimated role of plasmids in the circulation of ESBL/pAmpC genes. IMPLICATIONS: Despite the heterogeneity of the studies, two distinct scenarios emerged: predominantly intrasectoral ESBL/pAmpC-Ec circulation in HICs and significant intersectoral circulation in LMICs. These findings underscore the need for region-specific antimicrobial resistance control strategies, focusing on limiting human-to-human transmission in HICs and enhancing sanitation and biosecurity in LMICs.
引用
- Miltgen G, Berti V, Milenkov M, et al. Circulation of extended-spectrum β-lactamase and plasmid-borne cephalosporinase-producing Escherichia coli from a One Health perspective: a narrative review. Clin Microbiol Infect. 2025. PMID: 41380801. doi:10.1016/j.cmi.2025.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。